Wide Scale Testing Beginning for COVID-19 Vaccines

Researchers are making so much progress in developing a vaccine against COVID-19 that the first wide-scale testing could begin in a matter of weeks.

The New York Times Coronavirus Vaccine Tracker says a vaccine developed by the 10-year-old biotech company Moderna expects to start wide-scale testing this month. If it does, it would mark an almost unprecedented acceleration of the clinical testing process.

Typically, testing and approving a new vaccine takes two or three years. Sometimes more. But under the federal government’s Operation Warp Speed, Modena received a fast-track designation from the Food and Drug Administration. It also got a $483 million award to further its Covid-19 vaccine.

Through its Coronavirus Vaccine Tracker The Times is updating the status of all the vaccines that have reached human testing, along with a selection of promising vaccines still being tested in cells or animals. Because of the number and especially speed at which bioscience and pharmaceutical firms are moving to develop a successful vaccine, the Tracker is being updated almost every day.

The World Health Organization lists 149 different vaccine projects underway worldwide. 17 are in clinical evaluation, meaning they are being tested in humans, either in small groups to ensure their safety and basic efficacy, or in hundreds to see the effect among different age groups.

The Vaccine Tracker lists five vaccine candidates that are in or about to launch Phase III testing, the broadest testing category where thousands of volunteers are enlisted to determine if the vaccine is widely effective and how well it protects people from becoming infected. That’s the test Moderna expects to begin soon.

A vaccine developed by AstraZeneca and the University of Oxford is already in Phase III testing in Brazil and South Africa and is in a simultaneous Phase II and III study in Europe. This program, like Moderna’s, is part of Operation Warp Speed.

The Vaccine Tracker lists two Chinese firms – Sinovac Biotech and Sinopharm – as ready to soon start broad testing of their respective vaccines. Sinopharm’s testing will be conducted in the United Arab Emirates. Sinovac plans to conduct its Phase III study in China and Brazil.

A fifth vaccine, which is not a vaccine specifically for COVID-19, but a sort of immune system booster, is being tested in Australia. Bacillus Calmette-Guerin, a vaccine originally developed for tuberculosis, has been found over its 100 year history to help fight off other types of infections and parasites. The Phase III testing will determine if it also helps protect against COVID-19.

Image by Angelo Esslinger

Is Curiosity a Recruiter’s Superpower?
General Interest

Is Curiosity a Recruiter’s Superpower?

Best Practices for Performance Reviews
General Interest

Best Practices for Performance Reviews

Cultural Sensitivity in the Workplace
General Interest

Cultural Sensitivity in the Workplace

#WeAreGreenKey: Spotlight on Tim Coonan
Architecture + Engineering General Interest

#WeAreGreenKey: Spotlight on Tim Coonan

Green Key Unlocked: Soft Skills Recruiters Should Have in the Age of AI
General Interest

Green Key Unlocked: Soft Skills Recruiters Should Have in the Age of AI

The Power of Feedback in The Workplace
General Interest

The Power of Feedback in The Workplace

#WeAreGreenKey: Spotlight on Ariana Ali
General Interest Worklife

#WeAreGreenKey: Spotlight on Ariana Ali

Green Key Named Best Executive Search Firm in Hedgeweek Awards
Accounting + Finance General Interest

Green Key Named Best Executive Search Firm in Hedgeweek Awards

LinkedIn Reaches 1B Users and Launches New AI Tools
General Interest

LinkedIn Reaches 1B Users and Launches New AI Tools

The Soft Skills Tech Talent Need
General Interest Information Technology

The Soft Skills Tech Talent Need

Upskilling: Your Path to Personal and Professional Growth
General Interest

Upskilling: Your Path to Personal and Professional Growth

#WeAreGreenKey: Spotlight on Trisha Hankins
General Interest Healthcare

#WeAreGreenKey: Spotlight on Trisha Hankins

Green Key Unlocked: Navigating a Career Transition to Analytics
General Interest Information Technology

Green Key Unlocked: Navigating a Career Transition to Analytics

Team Dynamics Deciphered: A Guide to Finding Your Place as a New Member
General Interest Worklife

Team Dynamics Deciphered: A Guide to Finding Your Place as a New Member

#WeAreGreenKey: Spotlight on Krista Zielinski
General Interest Pharma

#WeAreGreenKey: Spotlight on Krista Zielinski

We Stand with Israel
General Interest

We Stand with Israel

Time Blindness: Impact and Management
General Interest Human Resources

Time Blindness: Impact and Management

Things You Shouldn’t Say During the Salary Negotiation Process
General Interest Human Resources Professional Support Worklife

Things You Shouldn’t Say During the Salary Negotiation Process

Salary Negotiations: Strategize Your Worth
General Interest Human Resources Professional Support

Salary Negotiations: Strategize Your Worth

#WeAreGreenKey: Spotlight on Brad Martin
Architecture + Engineering General Interest

#WeAreGreenKey: Spotlight on Brad Martin

Latest Blog Posts
View All Posts
Is Curiosity a Recruiter’s Superpower?

Is Curiosity a Recruiter’s Superpower?

As the recruitment landscape continues to evolve, one skill stands out as a game changer: curiosity.
Read More
Best Practices for Performance Reviews

Best Practices for Performance Reviews

Performance reviews, often met with anxiety and anticipation, are an integral part to a thriving workplace and the cornerstone of...
Read More
Cultural Sensitivity in the Workplace

Cultural Sensitivity in the Workplace

Cultural sensitivity is a pivotal factor in creating a workplace where every individual can flourish.
Read More